1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Nexstar Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis nebulised liposomal amphotericin B - Aspergillosis | Phase 2 / Phase 3 | Completed | Erasmus Medical Center | 320 | 2000-01-01 | 2006-08-18 |
Aspergillosis (1) · Hematologic Diseases (1) · Mycoses (1) · Neutropenia (1)
Netherlands (1)
A Vulto, PhD (1) · Bart JA Rijnders, MD, PhD (1) · Jan J Cornelissen, MD, PhD (1) · Lennert Slobbe, MD (1) · M J Becker, PhD (1) · Siem de Marie, MD, PhD (1)